Jefferson M. Jones - Concepedia

Author

Jefferson M. Jones

Centers for Disease Control and Prevention ORCID

Also Known As

Emily Curren, J Jones, J M Jones, J. Jones, J. M. JONES, J. M. Jones, J.M. JONES, J.M. Jones, Jefferson Jones, Jefferson Jones II

160

Publications

5.4K

Citations

H-Index

124

Concepts

All Affiliations

Centers for Disease Control and Prevention Keele University American Red Cross Pacific Research Institute Vitalant

About

Jefferson M. Jones is an author at Centers for Disease Control and Prevention specializing in medicine, epidemiology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	2.3K
2	Public Health	14	15	1.9K
3	Health Sciences	4	4	157
4	Nursing	3	3	98
5	Education	1	1	46

Jefferson M. Jones

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
An audit of outcome of treatment in acromegaly Andrew Bates, William van’t Hoff, Jefferson M. Jones, QJM Geriatric EndocrinologyMetabolic SyndromeHypertensionEpidemiologyGrowth Hormone	1993	467
Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 Kristie E.N. Clarke, Jefferson M. Jones, Yangyang Deng, MMWR Morbidity and Mortality Weekly Report Virus EpidemiologyImmunologyPopulation Health SciencesCovid-19 EpidemiologyUnited States	2022	320
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 Jefferson M. Jones, Katherine E. Fleming-Dutra, Mila M. Prill, MMWR Morbidity and Mortality Weekly Report Respiratory Virus ImmunityRespiratory ComplicationsPediatric Lung DiseaseAdvisory CommitteeMaternal Immunization	2023	304
Seasonality of Respiratory Syncytial Virus — United States, 2017–2023 Sarah Hamid, Amber Winn, Rishika Parikh, MMWR Morbidity and Mortality Weekly Report	2023	282
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 Katherine E. Fleming-Dutra, Jefferson M. Jones, Lauren E. Roper, MMWR Morbidity and Mortality Weekly Report	2023	237
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021 Jefferson M. Jones, Mars Stone, Hasan Sulaeman, JAMA	2021	214
The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021 Sarah Mbaeyi, Sara E. Oliver, Jennifer P. Collins, MMWR Morbidity and Mortality Weekly Report ImmunodeficienciesImmunologyCovid-19 VaccinesAdvisory CommitteeVaccine Hesitancy	2021	173
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021 Kate R. Woodworth, Danielle Moulia, Jennifer P. Collins, MMWR Morbidity and Mortality Weekly Report	2021	167
Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status — United States, April 2021–September 2022 Jefferson M. Jones, Irene Molina Manrique, Mars Stone, MMWR Morbidity and Mortality Weekly Report	2023	144
Risk Behaviors for Contact Lens–Related Eye Infections Among Adults and Adolescents — United States, 2016 Jennifer R. Cope, Sarah A. Collier, Hannah Nethercut, MMWR Morbidity and Mortality Weekly Report Ocular DiseaseRisk BehaviorsInjury PreventionOcular Surface PhysiologyPreventive Medicine	2017	127

Page 1